GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Deferred Policy Acquisition Costs

Biotech Growth Trust (The) (LSE:BIOG) Deferred Policy Acquisition Costs : £0.00 Mil (As of Mar. 2025)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs represent the costs incurred by insurance companies for policy acquisitions that has not been paid.


Biotech Growth Trust (The) Deferred Policy Acquisition Costs Historical Data

The historical data trend for Biotech Growth Trust (The)'s Deferred Policy Acquisition Costs can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Deferred Policy Acquisition Costs Chart

Biotech Growth Trust (The) Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Deferred Policy Acquisition Costs
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotech Growth Trust (The) Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Deferred Policy Acquisition Costs Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotech Growth Trust (The) Business Description

Traded in Other Exchanges
N/A
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. Its performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Biotech Growth Trust (The) Headlines

No Headlines